Literature DB >> 15028582

Endogenous beta-carbolines as clonidine-displacing substances.

E S J Robinson1, N J Anderson, J Crosby, D J Nutt, A L Hudson.   

Abstract

Endogenous beta-carbolines, such as harmane, are known to occur in mammalian species including humans. Radioligand binding studies have revealed that certain beta-carbolines display high affinity for both I(1) and I(2) imidazoline-binding sites (IBS). Functional studies have shown that the beta-carboline harmane elicits many characteristics expected of an endogenous ligand IBS. This article discusses the evidence relating to beta-carbolines as endogenous ligands and presents a case for harmane and related compounds as endogenous ligands for IBS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15028582     DOI: 10.1196/annals.1304.018

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.

Authors:  David J Wagner; Haichuan Duan; Alenka Chapron; Richard W Lee; Joanne Wang
Journal:  Xenobiotica       Date:  2017-03-02       Impact factor: 1.908

2.  Harmane inhibits serotonergic dorsal raphe neurons in the rat.

Authors:  Khalid Touiki; Pascal Rat; Robert Molimard; Abderrahman Chait; Renaud de Beaurepaire
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

3.  Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer.

Authors:  Binbing Ling; Lifeng Chen; Jane Alcorn; Baohua Ma; Jian Yang
Journal:  Invest New Drugs       Date:  2009-12-30       Impact factor: 3.850

4.  Screening of Norharmane from Seven Cyanobacteria by High-performance Liquid Chromatography.

Authors:  Tunay Karan; Ramazan Erenler
Journal:  Pharmacogn Mag       Date:  2017-10-11       Impact factor: 1.085

5.  Metabolite profile resulting from the activation/inactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 2-methyltetrahydro-β-carboline by oxidative enzymes.

Authors:  Tomás Herraiz; Hugo Guillén; Juan Galisteo
Journal:  Biomed Res Int       Date:  2013-07-28       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.